SUNWELS Co.,Ltd. (9229) AI Stock Analysis

• Market Cap: ¥20.92B
• Dividend Yield: N/A
• Average Volume (3M): 115.88K
• Price to Earnings (P/E): 159.7
• Beta (1Y): 1.14
• Revenue Growth: 20.41%
• EPS Growth: -251.04%
• Country: JP
• Employees: 2,435
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): -22.35
• Shares Outstanding: 35,220,000
• 10 Day Avg. Volume: 157,720
• 30 Day Avg. Volume: 115,876
• PEG Ratio: 0.09
• Price to Book (P/B): 2.13
• Price to Sales (P/S): 0.69
• P/FCF Ratio: -7.88
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 44 Neutral
• Price Target: ¥560.00 ▼(-2.95% Downside)

SUNWELS Co.,Ltd. faces significant challenges, primarily due to its financial performance and valuation. The company's high leverage, negative net income, and cash flow issues are major concerns. Additionally, technical indicators suggest bearish momentum, and the negative P/E ratio highlights valuation risks. These factors collectively result in a low overall stock score.

SUNWELS Co.,Ltd. Business Overview & Revenue Model

Company Description

Sunwels Co.,Ltd. operates nursing care business centered on PD house. It operates homes for the elderly that specializes in Parkinson disease, as well as a Kaatsu training gym; provides day care, in-home care support, care plan, and home remodeling services; and operates medical specific facilities. Sunwels Co.,Ltd. was incorporated in 2006 and is headquartered in Kanazawa, Japan.

How the Company Makes Money

SUNWELS Co., Ltd. generates revenue primarily through the sale of its solar energy products, including solar panels and inverters, which are sourced from various suppliers and manufactured in-house. The company also earns income from energy storage solutions and related services, such as installation and maintenance. Key revenue streams include direct sales to consumers, partnerships with renewable energy developers, and government contracts for solar energy projects. Additionally, SUNWELS benefits from strategic collaborations with technology firms to enhance product offerings and expand market reach, contributing significantly to its earnings.

SUNWELS Co.,Ltd. Financial Statement Overview

Summary

SUNWELS Co.,Ltd. demonstrates strong revenue growth but faces profitability and cash flow challenges. High leverage and negative net income in 2025 are key concerns. The company needs to focus on improving operational efficiency and managing debt levels to enhance financial stability.

Income Statement

SUNWELS Co.,Ltd. has shown significant revenue growth over the years, with a notable increase from 2020 to 2025. However, the company is facing challenges in profitability, as indicated by a negative net profit margin in 2025. The gross profit margin has decreased over time, and the EBIT and EBITDA margins have also shown volatility, reflecting operational inefficiencies.

Balance Sheet

The company has a high debt-to-equity ratio, indicating significant leverage, which poses a risk. The return on equity has been inconsistent, with a negative ROE in 2025 due to negative net income. The equity ratio has improved over the years, suggesting a gradual strengthening of the equity base relative to total assets.

Cash Flow

SUNWELS Co.,Ltd. has experienced fluctuations in free cash flow, with negative free cash flow in recent years, highlighting cash management challenges. The operating cash flow to net income ratio is strong, indicating good cash generation relative to reported earnings. However, the free cash flow to net income ratio is concerning due to negative free cash flow.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	26.46B	26.50B	21.36B	13.72B	8.42B	5.40B
Gross Profit	3.59B	4.92B	6.42B	3.75B	2.11B	1.38B
EBITDA	1.84B	1.88B	4.35B	1.45B	819.00M	562.83M
Net Income	-2.17B	-925.00M	802.00M	303.00M	255.71M	241.42M
Balance Sheet
Total Assets	42.22B	38.99B	31.52B	19.21B	9.02B	4.79B
Cash, Cash Equivalents and Short-Term Investments	3.62B	5.64B	3.31B	2.61B	814.76M	496.36M
Total Debt	26.35B	22.49B	20.11B	11.20B	6.60B	3.03B
Total Liabilities	34.32B	30.37B	24.38B	13.84B	8.15B	4.09B
Stockholders Equity	7.89B	8.62B	7.14B	4.61B	864.74M	693.47M
Cash Flow
Free Cash Flow	0.00	-2.32B	-2.94B	-741.00M	-78.18M	-392.99M
Operating Cash Flow	0.00	1.88B	2.56B	1.14B	378.19M	201.03M
Investing Cash Flow	0.00	-4.40B	-5.66B	-2.04B	-633.05M	-648.06M
Financing Cash Flow	0.00	4.84B	3.80B	2.70B	573.26M	489.42M

SUNWELS Co.,Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 577.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9229, the sentiment is Negative. The current price of 577 is below the 20-day moving average (MA) of 611.80, below the 50-day MA of 699.76, and below the 200-day MA of 634.96, indicating a bearish trend. The MACD of -29.70 indicates Negative momentum. The RSI at 35.29 is Neutral, neither overbought nor oversold. The STOCH value of 43.34 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:9229.

SUNWELS Co.,Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2374	79 Outperform	¥21.98B	12.55	―	3.41%	4.31%	-9.01%
7133	74 Outperform	¥9.44B	13.24	―	1.51%	18.30%	37.13%
7061	71 Outperform	¥11.80B	20.92	―	1.09%	20.37%	-5.97%
6059	69 Neutral	¥6.71B	3.00	―	2.79%	0.92%	1344.43%
6557	65 Neutral	¥9.24B	26.06	―	―	11.69%	-38.92%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
9229	44 Neutral	¥20.92B	159.73	―	―	20.41%	-251.04%

SUNWELS Co.,Ltd. Corporate Events

Sunwels Co., Ltd. Reports Q1 FY 2026 Financial Results with Focus on Healthcare Initiatives

Sunwels Co., Ltd. has announced its financial results for the first quarter of FY March 2026, highlighting its commitment to addressing healthcare challenges through initiatives like the ‘PD House’ for Parkinson’s disease. This strategic focus is expected to enhance the company’s positioning in the healthcare sector and contribute to societal sustainability.

SUNWELS Co.,Ltd. Reports First Quarter Loss Amidst Financial Challenges

SUNWELS Co.,Ltd. reported a challenging first quarter for the fiscal year ending June 30, 2025, with a net loss of ¥725 million, a significant decline from the previous year’s profit. The company’s financial position weakened with a decrease in net assets and equity ratio, and no dividends were declared. Despite the setback, the company maintains its sales forecast for the full year, indicating a cautious optimism about future performance.